美股新聞 標題聯播 · 近 24 小時 337 則 · 29 個來源 · 最新 9/20 04:53
本站只列標題、來源、時間與原文連結,不重製內文;著作權屬原媒體與原作者。新聞稿通路(PR Newswire、Business Wire、GlobeNewswire)是公司自己發的,屬第一手;媒體是轉述。
全部 · CNTX近 30 天 1 則 · 第 1 / 1 頁
- Context Therapeutics Announces First Patient Dosed in Phase 1 Trial of CT-202
- Context drops bispecific T-cell engager on cost-cutting initiative
- Endometrial Cancer Market Share Analysis and Industry Trends (2026-2031) Featuring Merck, Eisai, Karyopharm Therapeutics, Context Therapeutics, Seagen and More
- Context Therapeutics Reports Second Quarter 2026 Operating and Pipeline Progress
- Context Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- Context Therapeutics Added to Russell 2000® and Russell 3000® Indexes
- Maxim Says Context Therapeutics (CNTX)’s Share Pullback Is an Overreaction; Remains Bullish
- CNTX Hits Worst Day In History After Ovarian Cancer Trial Data — But Analysts See Buying Opportunity In Dip
- Small Biotech Context Therapeutics Reports 29% Response Rate In Ovarian Cancer Study
- Context Therapeutics Announces Positive Interim Efficacy and Safety Results from Ongoing Phase 1 Clinical Trial for CTIM-76
- Context Therapeutics to Present at the Jefferies Global Healthcare Conference
- Context Therapeutics Enters into License Agreement Amendment with BioAtla for CT-202
- Context Therapeutics Reports First Quarter 2026 Operating and Financial Results
- Positive Signs As Multiple Insiders Buy Context Therapeutics Stock
- Context Therapeutics Announces CTIM-76 Receives FDA Fast Track Designation for the Treatment of Platinum-Resistant Ovarian Cancer
- Context Therapeutics Reports Full Year 2025 Operating and Financial Results
- Context Therapeutics Announces Poster Presentation at the American Association for Cancer Research (AACR) Annual Meeting 2026
- Context Therapeutics CEO Teases Q2 Claudin 6 Data, Nectin-4 Clinic Entry at TD Cowen Conference
中文標題是機器翻譯(NLLB 模型,不外送資料),專有名詞靠對照表,語意以英文原題為準。預設藏掉:選股文與自動生成站(Motley Fool、24/7 Wall St、Trefis、MarketBeat…)、加密幣、律師事務所的股東訴訟廣告、非英文、新聞稿裡的人事任命 / 出席活動 / 得獎、個人理財專欄,以及通路稿標題對不到上市公司的。個股標籤是從標題辨識的(通路標準寫法 (NASDAQ: NVDA)、公司名對照);帶「?」的是從摘要辨識、信心較低。來源等級 A / B / C 只影響精選排序,不是對媒體的評價。